Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model

類似資料

• SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells
  著者:: Wang, Zhiqiang, 等
  出版事項: (2012)
• ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance
  著者:: Wang, Zhiqiang, 等
  出版事項: (2014)
• BCR-ABL Gene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia
  著者:: Yuan, Hongfeng, 等
  出版事項: (2010)
• Novel approaches to therapy in CML
  著者:: Bhatia, Ravi
  出版事項: (2017)
• A convenient cell culture model for CML acquired resistance through BCR-ABL mutations
  著者:: Wang, Zhiqiang, 等
  出版事項: (2016)